At a glance

ClinicalIndex Comparison Record

N/ACompleted· 240 enrolled

Drug / intervention

Sodium dichloroisocyanurate (NaDCC) tablets +1 moreother

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00252928

NCT00252928N/ACompleted

Compare CT.gov

Health Impact Study of a Water Treatment Tablet, Aquatabs, in Tamale, Ghana

Centers for Disease Control and Prevention·interventional·Posted Nov 15, 2005·Updated Oct 30, 2007

In Brief

A clinical study evaluating Sodium dichloroisocyanurate (NaDCC) tablets and Placebo for Diarrhea. Completed, enrolled 240 participants across 3 sites in 2 countries.

Detailed Summary

The purpose of this study to determine whether Aquatabs, a water treatment tablet, reduces diarrheal diseases in a peri-urban population of Tamale, Ghana.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsDiarrhea

CountriesGhana, United States

CollaboratorsMedentech, Emory University Center for Global Safe Water, NewEnergy, University for Development Studies, Tamale, Ghana

Timeline

N/ACompletedFinished

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

First PostedNov 2005

Enrollment StartJul 2006

Study CompletionNov 2006

TodayJul 2026

First PostedNov 15, 2005

Enrollment StartJul 1, 2006

Study CompletionNov 1, 2006

TodayJul 2, 2026

Posted 20.6 years ago

Interventions

Sodium dichloroisocyanurate (NaDCC) tabletsother

Intervention arm receives NaDCC tablets to use for to disinfect their household water for use for 20L of water. Ideally, disinfection occurs every day.

Placeboother

Placebo